Meningitis, Bacterial

It is caused by bacterial infection. The supplied grounding also indicates that pathogen distribution and antimicrobial resistance are important microbiologic aspects of the disease, but it does not specify particular organisms.

The disease reflects bacterial invasion of the meningeal spaces, with associated inflammation in the central nervous system. The grounding also supports an inflammatory mechanism in which dysregulated cytokines and chemokines, microglial activation, and downstream neuroinflammatory injury contribute to tissue damage and adverse outcomes.

The supplied grounding supports higher burden and fatality in resource-limited settings, including regions within the African Meningitis Belt. It also indicates that epidemiology and pathogen distribution vary over time and by setting, but it does not provide specific individual risk factors.

The grounding supports treatment at the level of antibiotics, vaccination, and anti-inflammatory treatment as major management modalities discussed in the literature. It also notes antimicrobial resistance as a relevant consideration, but does not provide specific drug classes or regimens.